Interferon-gamma in alopecia areata

European Journal of Dermatology

Volumn 14, Issue 1, 2004, Pages 33-36

  Arca, Ercan ^a   Muşabak, Uǧur ^a   Akar, Ahmet ^a   Erbil, A Hakan ^a   Taştan, H Bülent ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Alopecia areata; Interferon gamma

Indexed keywords

GAMMA INTERFERON;

ADULT; ALOPECIA; ALOPECIA AREATA; ALOPECIA TOTALIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL;

ALOPECIA AREATA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE II; MALE; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0442313537     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hoffmann R. The potential role of cytokines and T-cells in alopecia oreata. J Investig Dermatol Symp Proc 1999; 4: 235-8.
2. Bodemer C, Peuchmaur M, Fraitoig S, Chotenoud L, Brousse N, de Prost Y. Role of cytotoxic T-cells in chronic alopecia areata. J Invest Dermatol 2000; 114: 112-6.
3. Yoshino T, Asada H, Ando Y, Fujii H, Yomaguchi Y, Yoshikawa K, Itami S. Impaired responses of peripheral blood mononuclear cells to T-cell stimulants in alopecia areata patients with a poor response to topical immunotherapy. Br J Dermatol 2001; 145: 415-21.
4. König A, Happle R, Hoffmann R. IFN-y-induced HLA-DR but not ICAM-I expression on cultured dermal papillacells is downregulated by TNF-a. Arch Dermatol Res 1997; 289: 466-70.
5. Teraki Y, Imanishi K, Shiohara T. Cytokines in alopecia oreata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis). Acta Derm Venereol (Stockh) 1996; 76: 421-3.
6. Olsen E, Hordinsky M, McDonald-Hull S, Price V, Roberts J, Shapiro J, Stenn K. Alopecia areata investigational assessment guidelines. J Am Acad Dermatol 1999; 40: 242-6.
7. McElwee KJ, Hoffmann R. Alopecia areata-animal models. Clin Exp Dermatol 2002; 27: 410-7.
8. Freyschmidth-Paul P, McElwee KJ, Happle R, Kissling S, Wenzel E, Sundberg JP, Zöller M, Hoffmann R. Interleukin-10-deficient mice are less susceptible to the induction of alopecia areata. J Invest Dermatol 2002; 119: 980-2.
9. Hoffmann R, Wenzel E, Huth A, Steen P, Scaufele M, Henninger HP. Cytokine MRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 1994; 103: 530-3.
10. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS. Autoimmune hair loss (alopecia areata) transferred by T-lymphocytes to human scalp explants on SCID mice. J Clin Invest 1998; 101: 62-7.
11. Gilhar A, Shalaginov R, Assy B, Serafimovich A, Kalish RS. Alopecia areata is a T-lymphocyte mediated autoimmune disease: Lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. J Investig Dermotol Symp Proc 1999; 4: 207-10.
12. scid mice. Arch Dermatol 2002; 138: 916-22.
13. scid mouse system is characterized by a Th1 response. Clinical Immunology 2003; 106: 181-7.
14. Sato-Kawamura M, Aiba S, Tagami H. Strong expression of CD40, CD54, and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Arch Dermatol Res 2003; 294: 536-43.
15. Griffiths CEM. The immunological basis of psoriasis. JEADV 2003; 17 (Suppl. 2): 1-5.
16. Abdel-Naser MB, Kruger-Krasagakis S, Krasogakis K, Gollnick H, Abdel-Fattah A, Orfanos CE. Further evidence for involment of both cell mediated and humoral immunity in generalized vitiligo. Pigment Cell Res 1994; 7: 1-8.
17. Kalish RS, Gilhar A. Alopecia areata: autoimmunity - the evidence is compelling. JID Symposium Proceedings 2003; 8: 164-7.
18. Skurkovich B, Skurkovich S. Anti-interferon-gamma antibodiesin the treatment of autoimmune diseases. Curr Opin Mol Ther 2003; 5: 52-7 (abstract).
19. D'Ovidio R, Claudatus J, Prima TD. Ineffectiveness of imiquimod therapy for alopecia totalis/universalis. JEADV 2002; 16: 416-17 (Letter).
20. th Congress of EADV. Munich, Germany, October 10-14, 2001. P32-25 (Abstract).